Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

CTNM

Contineum Therapeutics (CTNM)

Contineum Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CTNM
DateTimeSourceHeadlineSymbolCompany
17/12/202408:05Business WireContineum Therapeutics Initiates Patient Dosing in Phase 1b Positron Emission Tomography (PET) Trial of PIPE-791NASDAQ:CTNMContineum Therapeutics Inc
28/11/202409:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTNMContineum Therapeutics Inc
26/11/202400:05Business WireContineum Therapeutics to Attend the 7th Annual Evercore HealthCONx ConferenceNASDAQ:CTNMContineum Therapeutics Inc
21/11/202409:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTNMContineum Therapeutics Inc
19/11/202409:05Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CTNMContineum Therapeutics Inc
19/11/202400:05Business WireContineum Therapeutics Expands Clinical Development of PIPE-791 With FDA Authorization of Its Investigational New Drug (IND) Application for Chronic PainNASDAQ:CTNMContineum Therapeutics Inc
14/11/202408:05Business WireContineum Therapeutics to Attend Upcoming Investor ConferencesNASDAQ:CTNMContineum Therapeutics Inc
07/11/202408:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CTNMContineum Therapeutics Inc
07/11/202408:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTNMContineum Therapeutics Inc
07/11/202408:05Business WireContineum Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:CTNMContineum Therapeutics Inc
29/08/202406:05Business WireContineum Therapeutics to Present at Multiple Upcoming Investor ConferencesNASDAQ:CTNMContineum Therapeutics Inc
15/08/202408:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTNMContineum Therapeutics Inc
15/08/202402:46Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CTNMContineum Therapeutics Inc
15/08/202402:19Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:CTNMContineum Therapeutics Inc
14/08/202406:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTNMContineum Therapeutics Inc
14/08/202406:05Business WireContineum Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:CTNMContineum Therapeutics Inc
01/08/202406:05Business WireContineum Therapeutics Announces Publication of Encouraging Data in the Proceedings of the National Academy of Sciences on PIPE-307, Its M1 Receptor Selective Inhibitor, in Clinical Development for Relapse-Remitting Multiple SclerosisNASDAQ:CTNMContineum Therapeutics Inc
25/06/202406:05Business WireContineum Therapeutics Announces Appointment of Sarah Boyce to Board of DirectorsNASDAQ:CTNMContineum Therapeutics Inc
05/06/202406:05Business WireContineum Therapeutics to Present at the 45th Annual Goldman Sachs Healthcare ConferenceNASDAQ:CTNMContineum Therapeutics Inc
04/06/202407:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTNMContineum Therapeutics Inc
04/06/202407:43Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CTNMContineum Therapeutics Inc
04/06/202406:05Business WireContineum Therapeutics Announces Appointment of John Healy as General Counsel & Corporate SecretaryNASDAQ:CTNMContineum Therapeutics Inc
01/06/202407:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTNMContineum Therapeutics Inc
30/05/202407:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTNMContineum Therapeutics Inc
30/05/202407:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTNMContineum Therapeutics Inc
30/05/202407:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTNMContineum Therapeutics Inc
21/05/202406:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTNMContineum Therapeutics Inc
21/05/202406:05Business WireContineum Therapeutics Announces Appointment of Troy Ignelzi to Board of DirectorsNASDAQ:CTNMContineum Therapeutics Inc
17/05/202407:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CTNMContineum Therapeutics Inc
17/05/202406:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTNMContineum Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CTNM